UTHR:NASDAQ
United Therapeutics Corp
$487.61
arrow_downward
-0.54%(-2.63) 1D
$487.61
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Set 4, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa UTHR...
Buksan
$484.33
Mataas
$494.08
Mababa
$484.33
Mkt. cap
20.91B
Avg. na dami
534.68K
Dami
327.02K
P/E ratio
17.44
Mataas nang 52-wk
$609.35
Mababa nang 52-wk
$375.61
EPS
$27.96
Beta
0.56
Mga natitirang share
42.89M
Bilang ng mga empleyado
1K
Buksan
$484.33
Mataas
$494.08
Mababa
$484.33
Mkt. cap
20.91B
Avg. na dami
534.68K
Dami
327.02K
P/E ratio
17.44
Mataas nang 52-wk
$609.35
Mababa nang 52-wk
$375.61
EPS
$27.96
Beta
0.56
Mga natitirang share
42.89M
Bilang ng mga empleyado
1K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Zacks
·
1 araw ang nakalipas
United Therapeutics (UTHR) Down 8% Since Last Earnings Report: Can It Rebound?
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Tungkol sa United Therapeutics Corp
CEO-
Mga Empleyado1.4K
Itinatag1996
HeadquartersSilver Spring, Maryland, Estados Unidos
Sektor-
Websiteunither.com